Found 4 hits for monomerid = 50469368 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase Mer
(Homo sapiens (Human)) | BDBM50469368
(CHEMBL4284392)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(cc1F)S(=O)(=O)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(.63,-11.6,;1.96,-10.83,;3.3,-11.6,;4.63,-10.83,;4.63,-9.29,;5.96,-11.6,;7.3,-10.83,;7.3,-9.29,;8.63,-8.52,;9.96,-9.28,;11.44,-8.8,;12.35,-10.05,;11.44,-11.31,;12.19,-12.65,;13.72,-12.67,;14.47,-14.03,;13.67,-15.35,;14.41,-16.7,;12.13,-15.31,;11.39,-13.97,;9.96,-10.83,;8.63,-11.6,;12.15,-7.44,;13.69,-7.38,;14.41,-6.01,;13.58,-4.71,;12.03,-4.78,;11.33,-6.15,;9.79,-6.21,;14.29,-3.34,;12.95,-2.57,;14.28,-1.8,;15.83,-3.28,;16.65,-4.59,;18.19,-4.53,;18.91,-3.16,;20.45,-3.1,;18.09,-1.86,;16.54,-1.92,)| Show InChI InChI=1S/C28H39FN6O3S/c1-4-5-19(2)31-28-30-17-24-25(18-35(27(24)32-28)20-6-8-21(36)9-7-20)23-11-10-22(16-26(23)29)39(37,38)34-14-12-33(3)13-15-34/h10-11,16-21,36H,4-9,12-15H2,1-3H3,(H,30,31,32)/t19-,20-,21-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase receptor UFO
(Homo sapiens (Human)) | BDBM50469368
(CHEMBL4284392)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(cc1F)S(=O)(=O)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(.63,-11.6,;1.96,-10.83,;3.3,-11.6,;4.63,-10.83,;4.63,-9.29,;5.96,-11.6,;7.3,-10.83,;7.3,-9.29,;8.63,-8.52,;9.96,-9.28,;11.44,-8.8,;12.35,-10.05,;11.44,-11.31,;12.19,-12.65,;13.72,-12.67,;14.47,-14.03,;13.67,-15.35,;14.41,-16.7,;12.13,-15.31,;11.39,-13.97,;9.96,-10.83,;8.63,-11.6,;12.15,-7.44,;13.69,-7.38,;14.41,-6.01,;13.58,-4.71,;12.03,-4.78,;11.33,-6.15,;9.79,-6.21,;14.29,-3.34,;12.95,-2.57,;14.28,-1.8,;15.83,-3.28,;16.65,-4.59,;18.19,-4.53,;18.91,-3.16,;20.45,-3.1,;18.09,-1.86,;16.54,-1.92,)| Show InChI InChI=1S/C28H39FN6O3S/c1-4-5-19(2)31-28-30-17-24-25(18-35(27(24)32-28)20-6-8-21(36)9-7-20)23-11-10-22(16-26(23)29)39(37,38)34-14-12-33(3)13-15-34/h10-11,16-21,36H,4-9,12-15H2,1-3H3,(H,30,31,32)/t19-,20-,21-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 191 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |
Receptor-type tyrosine-protein kinase FLT3
(Homo sapiens (Human)) | BDBM50469368
(CHEMBL4284392)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(cc1F)S(=O)(=O)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(.63,-11.6,;1.96,-10.83,;3.3,-11.6,;4.63,-10.83,;4.63,-9.29,;5.96,-11.6,;7.3,-10.83,;7.3,-9.29,;8.63,-8.52,;9.96,-9.28,;11.44,-8.8,;12.35,-10.05,;11.44,-11.31,;12.19,-12.65,;13.72,-12.67,;14.47,-14.03,;13.67,-15.35,;14.41,-16.7,;12.13,-15.31,;11.39,-13.97,;9.96,-10.83,;8.63,-11.6,;12.15,-7.44,;13.69,-7.38,;14.41,-6.01,;13.58,-4.71,;12.03,-4.78,;11.33,-6.15,;9.79,-6.21,;14.29,-3.34,;12.95,-2.57,;14.28,-1.8,;15.83,-3.28,;16.65,-4.59,;18.19,-4.53,;18.91,-3.16,;20.45,-3.1,;18.09,-1.86,;16.54,-1.92,)| Show InChI InChI=1S/C28H39FN6O3S/c1-4-5-19(2)31-28-30-17-24-25(18-35(27(24)32-28)20-6-8-21(36)9-7-20)23-11-10-22(16-26(23)29)39(37,38)34-14-12-33(3)13-15-34/h10-11,16-21,36H,4-9,12-15H2,1-3H3,(H,30,31,32)/t19-,20-,21-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 189 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of FLT3 (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase receptor TYRO3
(Homo sapiens (Human)) | BDBM50469368
(CHEMBL4284392)Show SMILES CCC[C@H](C)Nc1ncc2c(cn([C@H]3CC[C@H](O)CC3)c2n1)-c1ccc(cc1F)S(=O)(=O)N1CCN(C)CC1 |r,wU:13.12,wD:16.16,3.3,(.63,-11.6,;1.96,-10.83,;3.3,-11.6,;4.63,-10.83,;4.63,-9.29,;5.96,-11.6,;7.3,-10.83,;7.3,-9.29,;8.63,-8.52,;9.96,-9.28,;11.44,-8.8,;12.35,-10.05,;11.44,-11.31,;12.19,-12.65,;13.72,-12.67,;14.47,-14.03,;13.67,-15.35,;14.41,-16.7,;12.13,-15.31,;11.39,-13.97,;9.96,-10.83,;8.63,-11.6,;12.15,-7.44,;13.69,-7.38,;14.41,-6.01,;13.58,-4.71,;12.03,-4.78,;11.33,-6.15,;9.79,-6.21,;14.29,-3.34,;12.95,-2.57,;14.28,-1.8,;15.83,-3.28,;16.65,-4.59,;18.19,-4.53,;18.91,-3.16,;20.45,-3.1,;18.09,-1.86,;16.54,-1.92,)| Show InChI InChI=1S/C28H39FN6O3S/c1-4-5-19(2)31-28-30-17-24-25(18-35(27(24)32-28)20-6-8-21(36)9-7-20)23-11-10-22(16-26(23)29)39(37,38)34-14-12-33(3)13-15-34/h10-11,16-21,36H,4-9,12-15H2,1-3H3,(H,30,31,32)/t19-,20-,21-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
UNC Eshelman School of Pharmacy
Curated by ChEMBL
| Assay Description Inhibition of TYRO3 (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay |
J Med Chem 61: 10242-10254 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01229 BindingDB Entry DOI: 10.7270/Q2K076ZK |
More data for this Ligand-Target Pair | |